Literature DB >> 2182847

Regulation of polypeptide growth factor synthesis and growth factor-related gene expression in the rat and mouse uterus before and after implantation.

J W Pollard1.   

Abstract

It is apparent that the uterus is a rich source of growth factors, the synthesis of which may be induced by female sex steroids. These growth factors appear to be involved in complex autocrine/paracrine regulatory circuits which in turn interact with steroid hormones. With the exception of CSF-1, however, detailed studies of the appearance of these growth factors and their receptors during pregnancy and under different hormonal regimens have yet to be performed. Furthermore, causative roles have not been established for any of these growth factors in uterine biology and pregnancy. In the near future we can expect that, by using in-situ techniques, the producing and responding cells will be identified. Cell culture models will also have to be established to investigate specific growth factor-induced functions. In the longer term, once more is known about the regulation of uterine growth factors, imaginative new experiments need to be designed, perhaps involving transgenic animals, to establish causative roles for growth factors in uterine biology.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2182847     DOI: 10.1530/jrf.0.0880721

Source DB:  PubMed          Journal:  J Reprod Fertil        ISSN: 0022-4251


  11 in total

1.  Stimulation of proliferation of bovine placental cells by products of activated mononuclear leukocytes.

Authors:  B G Low; P J Hansen; M Drost
Journal:  In Vitro Cell Dev Biol       Date:  1991-08

2.  Independently arising macrophage mutants dissociate growth factor-regulated survival and proliferation.

Authors:  J W Pollard; C J Morgan; P Dello Sbarba; C Cheers; E R Stanley
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

3.  Autologous endometrial co-culture in patients with repeated failures of implantation after in vitro fertilization-embryo transfer.

Authors:  L I Barmat; H C Liu; S D Spandorfer; A Kowalik; C Mele; K Xu; L Veeck; M Damario; Z Rosenwaks
Journal:  J Assist Reprod Genet       Date:  1999-03       Impact factor: 3.412

4.  Steroidal regulation of connective tissue growth factor (CCN2; CTGF) synthesis in the mouse uterus.

Authors:  M A Rageh; E E Moussad; A K Wilson; D R Brigstock
Journal:  Mol Pathol       Date:  2001-10

5.  A Baboon (Papio anubis) simulated-pregnant model: cell specific expression of insulin-like growth factor binding protein-1 (IGFBP-1), type I IGF receptor (IGF-1 R) and retinol binding protein (RBP) in the uterus.

Authors:  S Hild-Petito; K M Donnelly; J B Miller; H G Verhage; A T Fazleabas
Journal:  Endocrine       Date:  1995-09       Impact factor: 3.633

6.  Characterization of transforming growth factor-beta (TGF-beta) receptors on BeWo choriocarcinoma cells including the identification of a novel 38-kDa TGF-beta binding glycoprotein.

Authors:  E J Mitchell; K Lee; M D O'Connor-McCourt
Journal:  Mol Biol Cell       Date:  1992-11       Impact factor: 4.138

7.  IL-6 and G-CSF levels in amniotic fluid during the second trimester in normal and abnormal pregnancies.

Authors:  E Weimann; G Reisbach; J Reinsberg; M J Lentze
Journal:  Arch Gynecol Obstet       Date:  1995       Impact factor: 2.344

8.  Changes in cell surface and intracellular glycoproteins of trophoblastic giant cells during mouse placentation.

Authors:  M Azuma; Y Kanai; A Ogura; M Kurohmaru; Y Hayashi
Journal:  Histochemistry       Date:  1991

9.  Treatment with gonadotropins impaired implantation and fetal development in mice.

Authors:  G Ertzeid; R Storeng; T Lyberg
Journal:  J Assist Reprod Genet       Date:  1993-05       Impact factor: 3.412

10.  The clinical significance of inflammatory cytokines in primary cell culture in endometrial carcinoma.

Authors:  Harriet O Smith; Nicole D Stephens; Clifford R Qualls; Tal Fligelman; Tao Wang; Chang-Yun Lin; Elizabeth Burton; Jeffrey K Griffith; Jeffrey W Pollard
Journal:  Mol Oncol       Date:  2012-08-15       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.